학술논문
Phase 1 study of Zanidatamab Zovodotin (ZW49): Safety Profile and Recommended Dose (RD) in patients with Human Epidermal Growth Factor 2 (HER2)-positive solid cancers
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15388514